REYATAZ vs VEMLIDY

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. REYATAZ and VEMLIDY are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	REYATAZ	VEMLIDY
Rating	72/100	70/100
Pharmacy pays	~$52.63 /30	—
Type	RX	RX
Active ingredient	ATAZANAVIR SULFATE	TENOFOVIR ALAFENAMIDE FUMARATE
Manufacturer	Bristol Myers Squibb	Gilead Sciences Inc
Dosage forms	Capsule, Powder	Tablet
Drug class	Protease Inhibitor	—
Boxed warning	None	Boxed warning
Treats	Acquired Immunodeficiency Syndrome	Chronic Hepatitis B, Acquired Immunodeficiency Syndrome

reyataz vemlidy

Rating

72/100

70/100

Pharmacy pays

~$52.63 /30

—

Type

Active ingredient

ATAZANAVIR SULFATE

TENOFOVIR ALAFENAMIDE FUMARATE

Manufacturer

Bristol Myers Squibb

Gilead Sciences Inc

Dosage forms

Capsule, Powder

Tablet

Drug class

Protease Inhibitor

—

Boxed warning

None

Boxed warning

Treats

Acquired Immunodeficiency Syndrome

Chronic Hepatitis B, Acquired Immunodeficiency Syndrome

Frequently asked questions

Which is better-rated, Reyataz or Vemlidy?

By our independent rating, Reyataz scores higher — 3.6 vs 3.5 out of 5 for Vemlidy. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Reyataz and Vemlidy?

Reyataz contains Atazanavir Sulfate, while Vemlidy contains Tenofovir Alafenamide Fumarate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.